Home | Site map | Elsevier websites | Alerts
Elsevier
Product information search
Search all Elsevier sites
Search
Advanced Product Search
Go to Elsevier home page
SiteStat.jsp
CHEMISTRY AND PHYSICS OF LIPIDS
Chemistry and Physics of Lipids

Guide for Authors



Submission of Manuscripts
It is a condition of publication that all manuscripts must be written in clear and grammatical English and be submitted to the Chemistry and Physics of Lipids Web site at External link http://ees.elsevier.com/cpl/ . A submission letter should always accompany the submitted paper providing the following information:
a) The full name and address of the corresponding author (including telephone and fax numbers, and e-mail addresses).
b) Any known changes of address within a period of six months after submission of the paper.
c)The full title of the submitted paper.
d) A minimum of six suitable potential reviewers (please provide their name, email addresses, and institutional affiliation). When compiling this list of potential reviewers please consider the following important criteria: they must be knowledgeable about the manuscript subject area; must not be from your own institution; at least two of the suggested reviewers should be from another country than the authors' ; and they should not have recent (< four years) joint publications with any of the authors. However, the final choice of reviewers is at the editors' discretion.
e) Manuscripts cited as "in press" should be made available to referees in the form of preprints.

Organization of Manuscripts
a) Title page. The title should be concise, descriptive and informative. The names of the authors should be followed by their addresses and indicated by corresponding letters. Changes in address should be indicated by footnotes. The author(s) to whom correspondence and proofs should be sent should be indicated, giving a full address (including fax number and e-mail address). Authors are requested to select a maximum of six key words and to present them on the title page of the typescript. These key words will be used for indexing and abstracting. Indicate also if the paper is a "Review" or "Short Communication".
Note that short communications are considered for publication at the editors' discretion.
b) Abstract. An abstract not exceeding 150 words should summarize the objectives, procedures, results and conclusions of the research. It should be typed on a separate page and will appear at the beginning of the article.
c) Presentation of material. The text should be concise and organized in the conventional manner. An Introduction should state the purpose of the work in the context of current knowledge. Experimental Procedures should be brief but sufficiently detailed to allow for potential repetition of the work by others. Results may include tables and figures, and a Discussion should primarily deal with the interpretation of the results. When appropriate, especially in Short Communications, Results and Discussion sections may be combined.
d) Acknowledgments. Financial support, technical assistance, and other help or advice should be acknowledged in a separate paragraph at the end of the text.

References
1. Quote references in the text by first author's name and year. For two authors quote both names; for three or more authors, quote first author's name, et al.
2. At the end of the article, list references alphabetically by first author; include all authors' names, followed by initials and include full titles of publications.
Examples of references: a) to Journal articles: Hupfer, B., Ringsdorf, H., 1983. Spreading and polymerization behavior of diacetylene phospholipids at the gas-water interface. Chem. Phys. Lipids 33, 263-282. b) to books: Dahlén, G., 1990. Clinical significance of Lp[a] lipoprotein. In: Berg, K., Rettersøl, N., Refsum, F. (Eds.), From Phenotype to Gene in Common Disorders. Munksgaard, Copenhagen, pp. 163-178. The names of the journals should be abbreviated according to the list of serial title word abbreviations (ISDS. Paris, 1985. ISBN 2-904938-02-8). Unpublished results should not be listed in the References section. In the text they are mentioned as follows "(Tervoort, M.V., Glimcher, J., unpublished data)". When unpublished results are cited, the data should be provided for the Editors' information when essential for proper evaluation, or if requested. A personal communication should be mentioned in the text as follows: "(Tervoort, M.V. personal communication)". Authors should not make unauthorized use of personal communications. Personal communications are not to be included in the References section.

Tables and Figures
a) Each table and figure should be uploaded separately. Legends should accompany in a separate document.
b) Tables should be numbered in Arabic numerals (Table 1, 2, 3) and must have a title.
c) Figures should be numbered in Arabic numerals (Fig. 1, 2, 3). Illustrations will not be redrawn by the Publisher and therefore they should be submitted electronically. Actual magnification of all photomicrographs should be indicated.
d) Illustrations in colour in the printed issue can be accepted only if the authors defray the cost. However, if together with your accepted article you submit usable colour figures, then Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g., ScienceDirect and other sites) regardless of whether these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article.

Please note: Because of technical complications that can arise in converting color figures to "gray scale" (for the printed version should you not opt for color in print), please submit in addition usable black-and-white files corresponding to all the color illustrations.

A detailed guide on electronic artwork is available on our website: External link http://www.elsevier.com/artworkinstructions .

Nomenclature and Abbreviations
Standard nomenclature should be used throughout; unfamiliar or new terms, arbitrary abbreviations, and trade names should be defined when first used. Unnecessary symbols and abbreviations should be avoided.

Copyright Upon acceptance of an article, authors will be asked to sign a Journal Publishing Agreement (for more information on this and copyright, see External link http://www.elsevier.com/copyright ). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail or letter will be sent to the corresponding author confirming receipt of the manuscript together with a Journal Publishing Agreement form or a link to the online version of the agreement. If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier Global Rights Department, P.O. Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com. Requests may also be completed online via the Elsevier Homepage (External link http://www.elsevier.com/locate/permissions).

US National Institutes of Health (NIH) voluntary posting ("Public Access") policy.

Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see External link http://www.nih.gov/about/publicaccess/index.htm ) by posting the author's peer-reviewed manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.

Proofreading
Since acceptance is based upon the submitted version of the paper, it is essential that no new material be inserted in the text at the time of proofreading; furthermore, no alteration to style or meaning will be permitted at this stage. Any new material that the authors wish to introduce for reasons of scientific accuracy will be checked by the Editors, and a charge may be made for corrections. Authors are encouraged to return their proofs by fax.

E-Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 25 free paper offprints. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.

There is no page charge.

Printer-friendly version   Printer-friendly version
 Home | Site map | Privacy policy | Terms and Conditions | Feedback | A Reed Elsevier company
 Copyright © 2007 Elsevier B.V. All rights reserved.